Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE PHARMACOLOGICAL BASIS FOR THE RATIONAL USE OF ATABRINE IN THE TREATMENT OF MALARIA

JAMES A. SHANNON, DAVID P. EARLE JR., BERNARD B. BRODIE, JOHN V. TAGGART and ROBERT W. BERLINER
Journal of Pharmacology and Experimental Therapeutics August 1944, 81 (4) 307-330;
JAMES A. SHANNON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID P. EARLE JR.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BERNARD B. BRODIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN V. TAGGART
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT W. BERLINER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The important factors which are concerned with the physiological disposition of atabrine have been defined.

The distribution of atabrine in the blood is such that observations on its specific antimalarial action should be related to the concentration of the drug in the plasma and, perhaps, indirectly from this, to its concentration in plasma water. The plasma atabrine concentration achieved after single or serial doses is dominated by the tendency of the organs of the body to localize the material within them and by the slow rate at which the drug is degraded. These characteristics are reflected in the low plasma atabrine concentration which is reached after a single dose of atabrine as well as in the low rate of renal excretion. They also, together with the low excretion rate, are reflected in the slow rate of fall of the plasma atabrine concentration on the termination of therapy and by the progressive accumulation of the drug in the body when serial doses are administered over a period of days or weeks.

The administration of repeated doses eventually results in the attainment of an equilibrium between the amount of drug administered and its localization, degradation and excretion. Thereafter, fairly constant plasma atabrine concentrations are maintained with a continuation of the dosage schedule.

The practical importance of the above factors has been examined by a study of the plasma atabrine concentrations achieved in groups of individuals on various regimes of supressive and definitive therapy.

Footnotes

    • Received January 7, 1944.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 81, Issue 4
1 Aug 1944
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE PHARMACOLOGICAL BASIS FOR THE RATIONAL USE OF ATABRINE IN THE TREATMENT OF MALARIA
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE PHARMACOLOGICAL BASIS FOR THE RATIONAL USE OF ATABRINE IN THE TREATMENT OF MALARIA

JAMES A. SHANNON, DAVID P. EARLE, BERNARD B. BRODIE, JOHN V. TAGGART and ROBERT W. BERLINER
Journal of Pharmacology and Experimental Therapeutics August 1, 1944, 81 (4) 307-330;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE PHARMACOLOGICAL BASIS FOR THE RATIONAL USE OF ATABRINE IN THE TREATMENT OF MALARIA

JAMES A. SHANNON, DAVID P. EARLE, BERNARD B. BRODIE, JOHN V. TAGGART and ROBERT W. BERLINER
Journal of Pharmacology and Experimental Therapeutics August 1, 1944, 81 (4) 307-330;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
  • Antinociceptive Properties of Fenfluramine, a Serotonin Reuptake Inhibitor, in a Rat Model of Neuropathy
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics